 |
ASCIA submissions to PBAC lodged in January 2023
The March 2023 meeting agenda of the Pharmaceutical Benefits Advisory Committee (PBAC) includes applications for new or updated Pharmaceutical Benefits Scheme (PBS) listings of four products that are relevant to allergy and immunology - EleCare® LCP for CMA, Saphnelo® for SLE, Jorveza® for EoE, and Shingrix® vaccine to prevent herpes zoster (Shingles) and post-herpetic neuralgia.
ASCIA has lodged submissions in support of these applications, which can be accessed here. |
| |
|
 |
ASCIA anaphylaxis e-training feedback surveys
ASCIA anaphylaxis e-training courses for schools, children’s education/care services and community are regularly reviewed and updated. To help us continue to improve the courses a short survey is now included at the end of the courses, which will only take a few minutes to complete. All information collected will be anonymous.
ASCIA has provided accessible, consistent and evidence-based anaphylaxis e-training since 2010, which can be accessed here. |
| |
|
 |
ASCIA health professional e-training feedback surveys
ASCIA provides anaphylaxis, food allergy, allergic rhinitis and allergen immunotherapy e-training courses for health professionals, which are regularly reviewed and updated. The courses can be accessed here
To help us continue to improve the courses a short survey is now included at the end of the courses, which will only take a few minutes to complete. All information collected will be anonymous.
|
| |
|
 |
ASCIA pharmacist e-training feedback surveys
ASCIA provides anaphylaxis, food allergy and allergic rhinitis e-training courses for pharmacists, which are regularly reviewed and updated. The courses can be accessed here.
To help us continue to improve the courses a short survey is now included at the end of the courses, which will only take a few minutes to complete. All information collected will be anonymous.
|
| |
|
 |
National Blood Authority immunoglobulin updates
Immunoglobulin Governance Program Updates are available on the National Blood Authority (NBA) website.
They provide a snapshot of the current work program of the NBA and priorities in the immunoglobulin space.
Read more here
|
| |
|
 |
CHOICE allergen immunotherapy research study
CHOICE study coordinators are looking for clinicians to join them in an international multi-centre academic project which looks at factors that drive the prescription of allergen immunotherapy in real-life clinical settings.
Read more here
|
| |
|
 |
Allergy and immunology meetings in 2023
We look forward to seeing you at meetings this year, including, the ASCIA 2023 Conference in September, the ASCIA-DA CAL food allergy course in March (see below) and immunodeficiency meetings in April and May 2023. These meetings and other events are on the ASCIA Calendar
|
| |
|
 |
ASCIA-DA CAL Food Allergy Course for Dietitians March 2023
Registration is open for the ASCIA and Dietitians Australia (DA) Centre for Advanced Learning (CAL) Medical Nutrition Therapy in Food Allergy and Intolerance course for dietitians in Melbourne, 2-3 March 2023.
Limited places are available, so it is important to register early.
|
| |
|
 |
Donate to AIFA and make a difference
Thank you to our generous supporters, who have enabled the Allergy and Immunology Foundation of Australasia (AIFA) to provide over $620,000 to 27 research projects since 2014.
AIFA ensures that 100% of your tax-deductible donation will directly fund grants for allergy and immunology research. Read more here |
| |
|
 |
Improving access to quality healthcare for people with allergies
The National Allergy Council Shared Care project aims to improve access to quality healthcare for people with allergies, particularly in regional, rural and remote areas. ASCIA’s involvement in the project will include education and training of health professionals. Stakeholder meetings will be held in 2023.
To subscribe to communications about this project email info@nationalallergy.org.au with the subject SUBSCRIBE. |
| |
|
 |
Recent ASCIA website updates
New mammalian meat and tick allergy FAQ
Pharmac to fund EpiPens from February 2023
Updated ASCIA adrenaline injectors FAQ
Animation videos on ASCIA website
Voluntary recall of ALK peanut SPT batches
|
| |
|
 |
ASCIA webpages listed below are regularly updated
ASCIA Submissions
Publications
Research Studies
Locate a Specialist
Allergy/Immunology Positions
Conference, Meetings and Events Calendar
|
www.allergy.org.au | contact us
The purpose of ASCIA is to advance the science and practice of allergy and clinical immunology, by promoting the highest standard of medical practice, training, education and research, to improve the health and quality of life of people with allergic diseases, immunodeficiencies and other immune diseases.
AIFA is dedicated to improving the health of people with allergy and other immune diseases by funding medical research and raising awareness. 